Barrow, Hanley, Mewhinney & Strauss
CAH icon

Barrow, Hanley, Mewhinney & Strauss’s Cardinal Health CAH Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10
Closed -$1.12K – 307
2024
Q1 		$1.12K Hold
10
– – ﹤0.01% 273
2023
Q4 		$1.01K Hold
10
– – ﹤0.01% 284
2023
Q3 		$868 Hold
10
– – ﹤0.01% 288
2023
Q2 		$946 Hold
10
– – ﹤0.01% 280
2023
Q1 		$755 Hold
10
– – ﹤0.01% 286
2022
Q4 		$769 Hold
10
– – ﹤0.01% 283
2022
Q3 		$1K Hold
10
– – ﹤0.01% 274
2022
Q2 		$1K Hold
10
– – ﹤0.01% 287
2022
Q1 		$1K Hold
10
– – ﹤0.01% 306
2021
Q4 		$1K Hold
10
– – ﹤0.01% 331
2021
Q3 		$0 Hold
10
– – ﹤0.01% 319
2021
Q2 		$1K Hold
10
– – ﹤0.01% 317
2021
Q1 		$1K Hold
10
– – ﹤0.01% 317
2020
Q4 		$1K Hold
10
– – ﹤0.01% 316
2020
Q3 		$0 Hold
10
– – ﹤0.01% 323
2020
Q2 		$1K Hold
10
– – ﹤0.01% 313
2020
Q1 		$0 Hold
10
– – ﹤0.01% 350
2019
Q4 		$1K Hold
10
– – ﹤0.01% 314
2019
Q3 		$0 Sell
10
-851
-99% -$38.8K ﹤0.01% 318
2019
Q2 		$41K Sell
861
-1,624,579
-100% -$74.9M ﹤0.01% 320
2019
Q1 		$78.3M Sell
1,625,440
-7,456,437
-82% -$374M 0.14% 100
2018
Q4 		$405M Sell
9,081,877
-8,705,731
-49% -$454M 0.79% 39
2018
Q3 		$961M Sell
17,787,608
-14,885
-0.1% -$762K 1.52% 28
2018
Q2 		$869M Sell
17,802,493
-780,283
-4% -$44.2M 1.4% 29
2018
Q1 		$1.16B Buy
18,582,776
+706,543
+4% +$48.5M 1.85% 21
2017
Q4 		$1.1B Sell
17,876,233
-2,175,663
-11% -$135M 1.63% 28
2017
Q3 		$1.34B Sell
20,051,896
-795,052
-4% -$56.2M 2.02% 16
2017
Q2 		$1.62B Buy
20,846,948
+141,935
+0.7% +$10.7M 2.47% 8
2017
Q1 		$1.69B Sell
20,705,013
-659,740
-3% -$51.9M 2.54% 5
2016
Q4 		$1.54B Buy
21,364,753
+5,114,726
+31% +$370M 2.3% 8
2016
Q3 		$1.26B Buy
16,250,027
+3,729,921
+30% +$301M 1.92% 19
2016
Q2 		$977M Buy
12,520,106
+6,681,725
+114% +$533M 1.49% 29
2016
Q1 		$478M Sell
5,838,381
-7,416
-0.1% -$603K 0.73% 43
2015
Q4 		$522M Sell
5,845,797
-211,656
-3% -$18M 0.78% 41
2015
Q3 		$465M Sell
6,057,453
-331,687
-5% -$27.7M 0.72% 44
2015
Q2 		$534M Sell
6,389,140
-76,796
-1% -$6.78M 0.73% 45
2015
Q1 		$584M Sell
6,465,936
-278,481
-4% -$24M 0.79% 44
2014
Q4 		$544M Buy
6,744,417
+53,657
+0.8% +$4.24M 0.73% 45
2014
Q3 		$501M Buy
6,690,760
+69,796
+1% +$5.08M 0.68% 47
2014
Q2 		$454M Sell
6,620,964
-337,758
-5% -$23M 0.61% 48
2014
Q1 		$487M Sell
6,958,722
-1,573,395
-18% -$109M 0.7% 47
2013
Q4 		$570M Sell
8,532,117
-2,985,896
-26% -$182M 0.83% 44
2013
Q3 		$601M Buy
11,518,013
+984,013
+9% +$50M 0.96% 40
2013
Q2 		$497M Buy
+10,534,000
New +$481M 0.84% 40

Other funds holding CAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's CAH Position: Q2 2024 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Cardinal Health (CAH) in Q2 2024, closing a stake of 10 shares — an estimated $1.12K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in CAH in Q2 2013 and held it in 44 quarters. The position peaked at $1.69B in Q1 2017. 1,009 funds tracked by Wall St. Rank hold CAH as of Q2 2024.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Cardinal Health position as of Q2 2024 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 10 Cardinal Health shares in Q2 2024, an estimated $1.12K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Cardinal Health in Q2 2013 and held it in 44 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Cardinal Health position peaked at $1.69B in Q1 2017.
  • 1,009 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2024.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2024, filed 13 Aug 2024.